BI-3802 |
顺式-2-((6-((5-氯-2-(3,5-二甲基哌嗪-1-基)嘧啶-4-基)氨基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基)氧基)-N-甲基乙酰胺 |
2166387-65-9 |
EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 |
1448189-80-7 |
MHY1485 |
MHY1485 |
326914-06-1 |
ABT-199 |
ABT-199 |
1257044-40-8 |
WY-14643 |
匹立尼酸 |
50892-23-4 |
LDN212854 |
(LDN212854) |
1432597-26-6 |
Pitstop 2 |
化合物PITSTOP 2 |
1419320-73-2 |
ITD-1 |
ITD 1 |
1099644-42-4 |
GlyT2-IN-1 |
CS-2063 |
448947-81-7 |
MCB-613 |
4-乙基-2,6-双(吡啶-3-基亚甲基)环己酮 |
1162656-22-5 |
SKI II |
鞘氨醇激酶抑制剂 |
312636-16-1 |
(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
PD 0332991 HCl |
帕布昔利布盐酸盐 |
827022-32-2 |
1-Methyl-N-[2-methyl-4-[2-(2-methylphenyl)diazenyl]phenyl-1H-pyrazole-5-carboxamide |
1-甲基-N-[2-METHYL-4-[2-(2-甲苯基)二氮烯基]苯基-1H-吡唑-5-甲酰胺 |
301326-22-7 |
IKK Inhibitor III, BMS-345541 |
BMS-345541 |
445430-58-0 |
1-[(1,2-DIHYDRO-1-OXO-5-ISOQUINOLINYL)SULFONYL]HEXAHYDRO-1H-1,4-DIAZEPINE |
羟基法舒地尔 |
105628-72-6 |
CLONIDINE |
可乐定 |
4205-90-7 |
SD-208 |
SD-208 |
627536-09-8 |
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone |
ERASTIN |
571203-78-6 |